Monday, September 07, 2026 1:40 PM ET
4 days ago
Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge5 days ago
We're adding 2 stocks to our Bullpen watchlist because they meet these criteria5 days ago
This medical device stock looks like a gift for patient investors5 days ago
August was the month of the comeback kids. Cramer reviews what drove the biggest winners6 days ago
Trump strikes new drug pricing deals with nine midsized drugmakers6 days ago
BioCryst is profitable. Now it wants to buy more rare disease drugs10 days ago
How Taylor Farms became integral to America's food supply system10 days ago
FDA approves daily HIV pill from Gilead designed to simplify treatment10 days ago
HHS plans new FDA leadership roles for technology and drugs, sources say10 days ago
Why vaccination rates are falling in the U.S.13 days ago
BioMarin to acquire Alesta Therapeutics for $275 million17 days ago
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar18 days ago
Hims & Hers CEO says FTC lawsuit misunderstands how the company works20 days ago
The startup using AI to help rare disease families develop custom treatments20 days ago
Court rules companies can't import Gilead medications from overseas20 days ago
Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'25 days ago
Trump administration ends Medicaid, CHIP funding for gender-affirming care for children26 days ago
We're lifting our price target on Cardinal Health after issuing rosy profit guidance26 days ago
Trump wants to split the MMR vaccine. Experts say that's unlikely26 days ago
Jazz Pharmaceuticals to buy Actio Biosciences for $820 million27 days ago
Eli Lilly takes weight-loss pill battle global27 days ago
Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism27 days ago
New genetic tests are catching rare diseases before symptoms start27 days ago
Why we like Boeing's latest deal — plus, what to expect from this health stock27 days ago
Hunter Biden says Joe Biden's cancer has spread further, 'very painful'28 days ago
Cyclospora fears lead consumers to lose their appetite for salads30 days ago
Jim Cramer highlights 5 investing themes — and the stocks to buy for each1 month ago
Sen. Mitch McConnell says he's left rehab, will work from home1 month ago
CAMP4 advances rare disease treatment for SYNGAP1 into human trials1 month ago
Divide between Eli Lilly and Novo Nordisk is widening after latest earnings1 month ago
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale1 month ago